Large-scale testing (Phase 3)UnknownNCT00532727What this trial is testingTriple Negative Breast Cancer TrialWho this might be right forBreast Cancer Institute of Cancer Research, United Kingdom 400
Testing effectiveness (Phase 2)Ended earlyNCT01498588What this trial is testingTrial of Eribulin Followed by Doxorubicin & Cyclophosphamide for Her2-negative, Locally Advanced Breast CancerWho this might be right forBreast NeoplasmsBreast CancerBreast Tumors+3 more Emory University 7
Large-scale testing (Phase 3)Study completedNCT04799249What this trial is testingTrilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Gemcitabine and Carboplatin for Metastatic Triple-Negative Breast Cancer (TNBC)Who this might be right forTNBC - Triple-Negative Breast CancerBreast Cancer G1 Therapeutics, Inc. 194
Large-scale testing (Phase 3)Active Not RecruitingNCT04711252What this trial is testingA Comparative Study of AZD9833 Plus Palbociclib Versus Anastrozole Plus Palbociclib in Patients With ER-Positive HER2 Negative Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced DiseaseWho this might be right forER-Positive HER2-Negative Breast Cancer AstraZeneca 1,370
Post-approval studies (Phase 4)Looking for participantsNCT05525767What this trial is testingChemotherapy Combined With Bevacizumab Neoadjuvant Therapy for HER2-negative Breast CancerWho this might be right forSolid Tumor Hebei Medical University Fourth Hospital 75
Testing effectiveness (Phase 2)Study completedNCT03007992What this trial is testingMetronomic Treatment With Daily Oral Vinorelbine as First-line Chemotherapy in Patients With Advanced/Metastatic Hormone Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Breast CancerWho this might be right forMetastatic Breast Cancer Johannes Gutenberg University Mainz 9
Testing effectiveness (Phase 2)Looking for participantsNCT05768139What this trial is testingFirst-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid TumorsWho this might be right forBreast CancerSolid Tumors, Adult Eli Lilly and Company 880
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06339281What this trial is testingClinical Study of Apatinib Mesylate Combined With Doctor's Choice for Advanced Breast CancerWho this might be right forAdvanced Breast Cancer Li Huiping 68
Testing effectiveness (Phase 2)Looking for participantsNCT06942234What this trial is testingStudy of JSKN016 Combination Therapy in Inoperable Locally Advanced or Metastatic HER2-Negative Breast CancerWho this might be right forInoperable Locally Advanced HER2-Negative Breast CancerMetastatic HER2-Negative Breast Cancer Jiangsu Alphamab Biopharmaceuticals Co., Ltd 180
Testing effectiveness (Phase 2)Study completedNCT05963984What this trial is testingSamuraciclib in Combination With Fulvestrant in Metastatic or Locally Advanced Breast Cancer in Adult ParticipantsWho this might be right forMetastatic Breast CancerLocally Advanced Breast CancerBreast Cancer Carrick Therapeutics Limited 60
Testing effectiveness (Phase 2)Ended earlyNCT05932667What this trial is testingMilademetan and Fulvestrant in GATA3-mutant, ER+HER- Advanced or Metastatic Breast CancerWho this might be right forAdvanced or Metastatic Breast Cancer Institut Curie 1
Early research (Phase 1)Study completedNCT02418624What this trial is testingPhase I of Carboplatin-Olaparib Followed by Olaparib Monotherapy in Advanced CancerWho this might be right forBreast CancerOvarian CancerAdvanced Cancer The Netherlands Cancer Institute 25
Early research (Phase 1)Study completedNCT02154776What this trial is testingDose Escalation Study of LEE011 in Combination With Buparlisib and Letrozole in HR+, HER2-negative Post-menopausal Women With Advanced Breast Cancer.Who this might be right forAdvanced or Metastatic Breast Cancer Novartis Pharmaceuticals 13
Testing effectiveness (Phase 2)Looking for participantsNCT07285382What this trial is testingDifferent Doses of Dalpicicl Combined With Letrozole in the First-line Treatment of HR-positive, HER2-negative Advanced Breast CancerWho this might be right forHR Positive HER2 Negative Advanced Breast Cancer wanghaibo 120
Early research (Phase 1)Active Not RecruitingNCT05143229What this trial is testingAlpelisib And Sacituzumab Govitecan For Treatment Of Breast CancerWho this might be right forBreast Cancer University of Kansas Medical Center 18
Not applicableStudy completedNCT06705504What this trial is testingA Real-world Study of Effectiveness and Safety in HR+/HER2- Breast Cancer Patients Treated With Ribociclib or AlpelisibWho this might be right forHormone Receptor Positive HER-2 Negative Breast Cancer Novartis 435
Testing effectiveness (Phase 2)Ended earlyNCT03225547What this trial is testingStudy of Pembrolizumab and Mifepristone in Patients With Advanced HER2-negative Breast CancerWho this might be right forTriple Negative Breast NeoplasmsBreast Cancer University of Chicago 24
Large-scale testing (Phase 3)Ended earlyNCT02730091What this trial is testingA Open Study of Metronomic Oral Vinorelbine in Combination With Aromatase Inhibitors for the Treatment of Postmenopausal Women With Hormone Receptor Positive,HER2-negative, Advanced Breast Cancer Who Received no Prior Therapy for Advanced DiseaseWho this might be right forBreast Cancer Centre Hospitalier Universitaire de Besancon 98
Testing effectiveness (Phase 2)Study completedNCT00623233What this trial is testingGemcitabine Plus Bevacizumab in Locally Recurrent or Metastatic Breast CancerWho this might be right forMetastatic Breast CancerLocally Advanced Breast Cancer Eli Lilly and Company 52
Early research (Phase 1)Study completedNCT02058381What this trial is testingA Phase Ib Dose De-escalation Study With BYL719 in Premenopausal Patients With Locally Advanced or Metastatic Breast CancerWho this might be right forPre-menopausal Breast CancerPI3K Pathway Inhibition Novartis Pharmaceuticals 40